Bromodomain
Bromodomain(溴域)
Bromodomains are a family of evolutionarily conserved protein modules of approximately 110 amino acids that have been found in chromatin-associated proteins as well as nuclear histone acetyltransferases (HATs). Besides its role in chromatin remodeling, recent studies have identified that bromodomains, as acetyl-lysine binding domains, are able to recognize and bind ε–N-acetylated lysine residues in histone and non-histone proteins. The nuclear magnetic resonance (NMR) spectroscopic analysis reveals that the chemical structure of bromodomains, consisting of four left-handed α-helices (including αZ, αA, αB and αC) connected by two loops (ZA and BC loops), forms a deep hydrophobic cavity serving as the acetyl-lysine recognition site.
Bromodomain 相关产品(45)
- GC16531Bromodomain Inhibitor, (+)-JQ1CAS: 1268524-70-4纯度: >99.50%
A selective inhibitor of BET bromodomains
- GC16299BET bromodomain inhibitorCAS: 1380087-89-7纯度: >99.50%
BET 溴结构域抑制剂是从专利 WO/2015/153871A2 化合物实施例 11 中提取的一种有效的 BET 抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC16531 | Bromodomain Inhibitor, (+)-JQ1 | 1268524-70-4 | >99.50% | |
A selective inhibitor of BET bromodomains | ||||
| GC10174 | SGC-CBP30 | 1613695-14-9 | >99.50% | |
A potent inhibitor of CREBBP/EP300 bromodomains | ||||
| GC10382 | CPI-637 | 1884712-47-3 | >99.50% | |
An inhibitor of CBP/EP300 bromodomains | ||||
| GC10727 | Ischemin sodium salt | - | - | |
CBP bromodomain inhibitor | ||||
| GC10979 | PFI 4 | 900305-37-5 | >98.00% | |
A chemical probe for BRPF1 | ||||
| GC12440 | GSK 5959 | 901245-65-6 | >98.00% | |
An inhibitor of the BRPF1 bromodomain | ||||
| GC12588 | I-BRD9 | 1714146-59-4 | >99.50% | |
A BRD9 bromodomain inhibitor | ||||
| GC13014 | AZD 5153 | 1869912-39-9 | - | |
AZD 5153是BET/BRD4溴结构域的双价抑制剂,AZD 5153对BRD4的IC₅₀值为5nM,可同时结合BRD4的两个溴结构域,显著影响MYC、E2F和mTOR的转录程序,并抑制NSD3靶基因的表达。 | ||||
| GC13025 | GSK6853 | 1910124-24-1 | >99.00% | |
A selective chemical probe for the bromodomain of BRPF1 | ||||
| GC13187 | I-BET 151 hydrochloride | - | - | |
A BRD2, BRD3, and BRD4 inhibitor | ||||
| GC13822 | (-)-JQ1 | 1268524-71-5 | >99.50% | |
A selective inhibitor of BET bromodomains | ||||
| GC14168 | UMB-32 | 1635437-39-6 | - | |
An inhibitor of BRD4, TAF1, and TAF1L bromodomains | ||||
| GC14361 | PFI 3 | 1819363-80-8 | >98.00% | |
Probe for bromodomains of SMARCA2/4 and PB1(bromodomain 5) | ||||
| GC14655 | OXF BD 02 | 1429129-68-9 | - | |
OXF BD 02 是 BRD4(1)(BRD4 的第一个溴结构域)的选择性抑制剂,IC50 值为 382 nM。 | ||||
| GC15152 | PF-CBP1 | 1962928-21-7 | - | |
An inhibitor of the CBP and p300 bromodomains | ||||
| GC15175 | BAZ2-ICR | 1665195-94-7 | >98.50% | |
A BAZ2A/B bromodomain inhibitor | ||||
| GC15789 | GSK2801 | 1619994-68-1 | >99.50% | |
A probe for BAZ2A/B bromodomains | ||||
| GC16299 | BET bromodomain inhibitor | 1380087-89-7 | >99.50% | |
BET 溴结构域抑制剂是从专利 WO/2015/153871A2 化合物实施例 11 中提取的一种有效的 BET 抑制剂。 | ||||
| GC16611 | GW841819X | - | - | |
BET bromodomain inhibitor | ||||
| GC16726 | BI-7273 | 1883429-21-7 | >99.50% | |
A potent BRD9 bromodomain inhibitor | ||||
| GC16763 | NI-57 | 1883548-89-7 | >99.50% | |
A BRPF bromodomain inhibitor | ||||
| GC16817 | BI-9564 | 1883429-22-8 | >99.50% | |
A selective BRD9/7 bromodomain inhibitor | ||||
| GC17482 | OF-1 | 919973-83-4 | >98.00% | |
A bromodomain probe for BRPF proteins | ||||
| GC18750 | NEO2734 | 2081072-29-7 | >99.50% | |
NEO2734 (EP31670) 是一种口服有效的双重 p300/CBP 和 BET 溴结构域选择性抑制剂,对 p300/CBP 和 BET 溴结构域的 IC50 值均 <30 nM。 NEO2734 在 SPOP 突变型和野生型前列腺癌中具有活性。 | ||||
